Wednesday 21 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 1 month ago

FDA snubs Novartis bid to repurpose inflammation drug for heart attacks

The U.S. Food and Drug Administration has rejected Novartis s bid to repurpose a drug now approved for rare inflammatory diseases to be used in a group of heart attack survivors, the Swiss drugmaker said on Thursday.

Related news

Latest News
Hashtags:   

snubs

 | 

Novartis

 | 

repurpose

 | 

inflammation

 | 

heart

 | 

attacks

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources